Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
NCT00000264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2015-05-27
Summary
The purpose of this study is to examine the subjective, psychomotor, and reinforcing effects of combined alcohol and nitrous oxide intake in healthy volunteers.
Conditions
- Opioid-Related Disorders
- Substance-Related Disorders
Interventions
- DRUG
-
30% Nitrous oxide
- OTHER
-
0.35 g/Kg ethanol
- OTHER
-
0.7 g/Kg ethanol
- OTHER
-
0 g/Kg ethanol
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Chicago
lead OTHER
Principal Investigators
-
James Zacny, Ph.D. · University of Chicago
Study Design
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1997-09-30
- Primary Completion
- 1999-10-31
- Completion
- 1999-10-31
Countries
- United States
Study Locations
More Related Trials
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Pharmacotherapies for Alcoholism
NCT00768508 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults
NCT07176208 ·Status: RECRUITING ·Phase: PHASE1
-
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
NCT02823977 ·Status: WITHDRAWN ·Phase: PHASE4
-
Abuse and Addiction in ICU
NCT02951793 ·Status: UNKNOWN
-
Neuroscience of Alcohol and Marijuana Impaired Driving
NCT03431987 ·Status: UNKNOWN
-
Men, Mood, and Attention Study: Examination of Alcohol, State Anger, and Emotion Regulation Sexual Aggression
NCT04192448 ·Status: TERMINATED ·Phase: NA
-
Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
NCT00027079 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Mechanisms Underlying Nicotine and Alcohol Combinations
NCT02049268 ·Status: COMPLETED ·Phase: NA
-
Alcohol, Behavior, and Brain Imaging
NCT03930446 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
EtOH Interaction Study
NCT00887367 ·Status: COMPLETED ·Phase: PHASE1
-
Cannabidiol Effects on Blood Alcohol Level and Intoxication
NCT06105138 ·Status: COMPLETED ·Phase: NA
-
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol for Alcohol Use Disorder
NCT03904849 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Oxytocin Treatment of Alcohol Dependence
NCT02251912 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Dependence
NCT02275611 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
NCT00612352 ·Status: COMPLETED ·Phase: NA
-
Sex Differences in the Response to Abstinence From Alcohol.
NCT03827460 ·Status: RECRUITING ·Phase: PHASE1
-
The Behavioral Effects of Opioids and Alcohol
NCT04300751 ·Status: COMPLETED ·Phase: PHASE1
-
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
NCT00614328 ·Status: COMPLETED ·Phase: PHASE1
-
Neurosteroids and Acute Alcohol Intoxication in Humans
NCT00608686 ·Status: UNKNOWN ·Phase: PHASE1
-
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT05223829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effect of Endotoxin on Alcohol Consumption
NCT04527185 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine for Reduction of Alcoholic Relapse
NCT02649231 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
NCT04523922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2